Inside The Federal Government’s Legal Drug Business
What’s really killing people in the United States?
Unaffordable health care.
Obamacare was promised as a solution to skyrocketing health care costs.
It’s completely failed to deliver this promise.
In what can only be described as paradigm-shattering research on drug prices, the Journal of the American Medical Association has officially recognized why drug prices skyrocket in America. Big pharma is granted a monopoly by the state which effectively eliminates their competition and allows them to charge any price they want — so they do.
The new paper, published on August 23, The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform, set out to “review the origins and effects of high drug prices in the US market and to consider policy options that could contain the cost of prescription drugs.”
What the paper’s authors, Harvard Medical School doctors Aaron Kesselheim and Jerry Avorn, and jurist Ameet Sarpatwari, found and subsequently admitted, shatters the very assertion that government regulation in the market is needed to keep medical care costs low. In fact, their findings were quite to the contrary.
According to the paper:
The most important factor that allows manufacturers to set high drug prices is market exclusivity, protected by monopoly rights awarded upon Food and Drug Administration approval and by patents.
As a result, everyday Americans are left with paying the cost of a $600 epipen that has $1 of actual drug cost.
The greed of the Federal Government and large drug companies is literally killing the Middle Class in the United States.